Want to see HK:2453 full AI Analyst Report?
Concord Healthcare Group Co., Ltd. Class H (2453) Ratios
Concord Healthcare Group Co., Ltd. Class H Ratios
HK:2453's free cash flow for Q2 2026 was $-43.16M. For the 2026 fiscal year, HK:2453's free cash flow was decreased by $-14.29M and operating cash flow was $-28.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.54 | 0.63 | 0.30 | 0.84 | 0.20 |
| Quick Ratio | 0.52 | 0.60 | 0.27 | 0.75 | 0.19 |
| Cash Ratio | 0.26 | 0.18 | 0.03 | 0.14 | 0.03 |
| Solvency Ratio | -0.03 | -0.08 | -0.07 | -0.11 | -0.09 |
| Operating Cash Flow Ratio | -0.09 | -0.16 | 0.17 | -0.10 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -0.18 | -0.47 | 0.38 | -0.22 | 0.19 |
| Net Current Asset Value | $ -3.09B | $ -3.29B | $ -3.01B | $ -3.05B | $ -7.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.54 | 0.50 | 0.47 | 0.37 |
| Debt-to-Equity Ratio | 1.69 | 1.95 | 1.65 | 1.69 | -1.59 |
| Debt-to-Capital Ratio | 0.63 | 0.66 | 0.62 | 0.63 | 2.68 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.62 | 0.54 | 0.57 | 4.25 |
| Financial Leverage Ratio | 3.16 | 3.58 | 3.27 | 3.61 | -4.28 |
| Debt Service Coverage Ratio | -0.07 | -0.39 | -0.26 | -0.49 | -0.51 |
| Interest Coverage Ratio | -1.93 | -3.40 | -3.27 | -1.74 | -0.90 |
| Debt to Market Cap | 2.62 | 0.42 | 0.37 | 0.38 | 0.35 |
| Interest Debt Per Share | 4.29 | 4.64 | 4.14 | 4.37 | 4.07 |
| Net Debt to EBITDA | -46.14 | -15.45 | -15.08 | -7.67 | -6.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 6.95% | -17.32% | -12.08% | -41.82% | -19.71% |
| EBIT Margin | -47.58% | -79.45% | -60.26% | -99.50% | -93.53% |
| EBITDA Margin | -13.41% | -50.08% | -32.04% | -75.29% | -75.72% |
| Operating Profit Margin | -51.82% | -95.60% | -65.66% | -101.14% | -83.54% |
| Pretax Profit Margin | -67.41% | -125.12% | -80.31% | -137.06% | -177.75% |
| Net Profit Margin | -55.79% | -114.14% | -69.26% | -114.66% | -173.56% |
| Continuous Operations Profit Margin | -66.49% | -124.85% | -79.16% | -134.96% | -176.65% |
| Net Income Per EBT | 82.77% | 91.23% | 86.25% | 83.66% | 97.64% |
| EBT Per EBIT | 130.08% | 130.88% | 122.32% | 135.51% | 212.78% |
| Return on Assets (ROA) | -4.32% | -7.50% | -7.12% | -8.91% | -12.26% |
| Return on Equity (ROE) | -13.65% | -26.90% | -23.33% | -32.13% | 52.44% |
| Return on Capital Employed (ROCE) | -5.11% | -7.78% | -8.77% | -9.29% | -16.66% |
| Return on Invested Capital (ROIC) | -4.42% | -7.16% | -7.61% | -8.57% | -16.11% |
| Return on Tangible Assets | -5.40% | -8.72% | -8.51% | -11.27% | -14.15% |
| Earnings Yield | -21.89% | -6.00% | -5.59% | -7.73% | -12.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.51 | 2.01 | 7.09 | 4.32 | 3.42 |
| Payables Turnover | 5.04 | 4.06 | 4.75 | 5.12 | 6.52 |
| Inventory Turnover | 24.74 | 13.62 | 14.96 | 8.80 | 17.32 |
| Fixed Asset Turnover | 0.12 | 0.10 | 0.14 | 0.12 | 0.11 |
| Asset Turnover | 0.08 | 0.07 | 0.10 | 0.08 | 0.07 |
| Working Capital Turnover Ratio | -0.90 | -0.61 | -1.08 | -0.26 | -0.16 |
| Cash Conversion Cycle | 87.98 | 118.40 | -0.94 | 54.69 | 71.67 |
| Days of Sales Outstanding | 145.66 | 181.46 | 51.49 | 84.53 | 106.62 |
| Days of Inventory Outstanding | 14.76 | 26.79 | 24.39 | 41.48 | 21.07 |
| Days of Payables Outstanding | 72.44 | 89.85 | 76.82 | 71.31 | 56.01 |
| Operating Cycle | 160.41 | 208.26 | 75.88 | 126.01 | 127.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.15 | -0.26 | 0.30 | -0.13 | 0.06 |
| Free Cash Flow Per Share | -0.35 | -0.70 | 0.03 | -0.25 | -0.82 |
| Dividend Paid and CapEx Coverage Ratio | -0.77 | -0.59 | 1.10 | -1.14 | 0.07 |
| Capital Expenditure Coverage Ratio | -0.77 | -0.59 | 1.10 | -1.14 | 0.07 |
| Operating Cash Flow Coverage Ratio | -0.04 | -0.06 | 0.08 | -0.03 | 0.02 |
| Operating Cash Flow to Sales Ratio | -0.25 | -0.48 | 0.37 | -0.20 | 0.10 |
| Free Cash Flow Yield | -22.76% | -6.77% | 0.27% | -2.51% | -9.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.63 | -16.68 | -17.89 | -12.94 | -7.92 |
| Price-to-Sales (P/S) Ratio | 2.55 | 19.04 | 12.39 | 14.84 | 13.74 |
| Price-to-Book (P/B) Ratio | 0.62 | 4.49 | 4.17 | 4.16 | -4.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.39 | -14.78 | 368.60 | -39.90 | -11.06 |
| Price-to-Operating Cash Flow Ratio | -10.10 | -39.75 | 33.06 | -74.85 | 140.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -1.56 | 0.68 | 0.39 | -0.19 |
| Enterprise Value Multiple | -65.15 | -53.47 | -53.75 | -27.38 | -24.73 |
| Enterprise Value | 3.91B | 10.40B | 9.28B | 9.73B | 8.81B |
| EV to EBITDA | -65.15 | -53.47 | -53.75 | -27.38 | -24.73 |
| EV to Sales | 8.74 | 26.78 | 17.22 | 20.62 | 18.73 |
| EV to Free Cash Flow | -15.06 | -20.79 | 512.32 | -55.42 | -15.08 |
| EV to Operating Cash Flow | -34.61 | -55.91 | 45.95 | -103.96 | 192.07 |
| Tangible Book Value Per Share | 1.15 | 1.50 | 1.53 | 1.35 | -3.22 |
| Shareholders’ Equity Per Share | 2.45 | 2.30 | 2.41 | 2.35 | -2.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | 0.01 | 0.02 | 0.01 |
| Revenue Per Share | 0.60 | 0.54 | 0.81 | 0.66 | 0.66 |
| Net Income Per Share | -0.33 | -0.62 | -0.56 | -0.76 | -1.14 |
| Tax Burden | 0.83 | 0.91 | 0.86 | 0.84 | 0.98 |
| Interest Burden | 1.42 | 1.57 | 1.33 | 1.38 | 1.90 |
| Research & Development to Revenue | 0.06 | 0.08 | 0.07 | 0.09 | 0.09 |
| SG&A to Revenue | 0.42 | 0.67 | 0.37 | 0.45 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.36 | 0.42 | -0.47 | 0.17 | -0.05 |
Currency in CNY
